VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $103,000 | -99.9% | 7,688 | -25.4% | 0.03% | -34.1% |
Q2 2017 | $178,000,000 | +97.8% | 10,303 | +6.2% | 0.04% | +76.0% |
Q1 2017 | $90,000,000 | +55.2% | 9,703 | +143.1% | 0.02% | +150.0% |
Q4 2016 | $58,000,000 | +62265.6% | 3,992 | +5.7% | 0.01% | -41.2% |
Q3 2016 | $93,000 | +1062.5% | 3,775 | +792.4% | 0.02% | +466.7% |
Q2 2016 | $8,000 | -11.1% | 423 | +21.6% | 0.00% | 0.0% |
Q1 2016 | $9,000 | -89.5% | 348 | -59.0% | 0.00% | -90.6% |
Q4 2015 | $86,000 | +132.4% | 848 | +305.7% | 0.03% | +146.2% |
Q3 2015 | $37,000 | -72.6% | 209 | -65.7% | 0.01% | -72.3% |
Q2 2015 | $135,000 | +11.6% | 610 | -0.7% | 0.05% | +20.5% |
Q1 2015 | $121,000 | +61.3% | 614 | +17.4% | 0.04% | +56.0% |
Q4 2014 | $75,000 | -6.2% | 523 | -14.1% | 0.02% | +56.2% |
Q3 2014 | $80,000 | +73.9% | 609 | +42.0% | 0.02% | -33.3% |
Q2 2014 | $46,000 | – | 429 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |